Recombinant human ACE2 has been shown to prevent Ang II induced kidney disease and tubulointerstitial fibrosis [19] and to slow the progression of diabetic nephropathy in the Akita mouse model of type 1 diabetes by reducing renal Ang II levels and increasing Ang 1–7 [20]. Here, ANGPT1 is linked to kidney disorder.